We also identified two genes, epidermal growth factor-like domain-containing protein 6 (EGFL6) and follicular dendritic cell secreted protein (FDCSP), which were highly down-regulated after treatment with metformin compared to placebo in postmenopausal breast cancer survivors (Fig. 1b-c). The gene discussed is EGFL6; the disease is breast carcinoma.